MARKET

BOVNF

BOVNF

Bioinvent Intern
OTCPK
2.980
NaN%
Opening 09:30 04/07 EDT
OPEN
--
PREV CLOSE
6.63
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.980
52 WEEK LOW
2.980
MARKET CAP
196.10M
P/E (TTM)
-5.4330
1D
5D
1M
3M
1Y
5Y
1D
BioInvent Narrows Pipeline and Advances Lead Cancer Antibodies in Strategically Focused 2025
TipRanks · 03/31 10:49
BioInvent Secures €1 Million Milestone as Endometriosis Antibody Enters Phase 3
TipRanks · 03/26 15:02
BioInvent Calls 2026 AGM, Sets Governance and Voting Framework
TipRanks · 03/24 07:40
BioInvent Earnings Call: Strong Data, Tight Runway
TipRanks · 03/01 00:19
BioInvent doubles down on lead cancer antibodies as 2026 data catalysts loom
TipRanks · 02/26 08:39
BioInvent to Present 2025 Year-End Results in Investor Webcast
TipRanks · 02/26 08:37
BioInvent Taps Industry Heavyweights for Board as Cancer Pipeline Advances
TipRanks · 02/23 09:32
BioInvent Posts Strong Interim Data for BI‑1808 and KEYTRUDA Combo in Recurrent Ovarian Cancer
TipRanks · 01/05 07:21
More
About BOVNF
BioInvent International AB is a Sweden-based biopharmaceutical company, that develops antibody-based drugs for cancer therapies, with two ongoing programs in Phase l/ll clinical trials for the treatment of haematological cancer and solid tumors. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The Company has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.

Webull offers BioInvent International AB stock information, including OTCPK: BOVNF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BOVNF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BOVNF stock methods without spending real money on the virtual paper trading platform.